LGND · Ligand Pharmaceuticals Inc · Documents
$322.75
+5.42 (+1.71%)
At close · Oct 30
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$6.43B
Shares
20.00M
Volume · Oct 30
344.37K
Avg daily vol (3M)
241.18K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-06-13 | 2022-06-10 | |
| 10-Q | — | 2022-05-09 | 2022-03-31 | |
| 8-K | — | 2022-05-04 | — | |
| DEF 14A | — | 2022-04-22 | 2022-06-10 | |
| DEFA14A | — | 2022-04-22 | — | |
| 8-K | — | 2022-03-24 | 2022-03-23 | |
| 8-K | — | 2022-03-23 | — | |
| 10-K | — | 2022-02-28 | 2021-12-31 | |
| 8-K | — | 2022-02-17 | — | |
| 8-K | — | 2022-01-27 | 2022-01-26 | |
| 8-K | — | 2022-01-14 | — | |
| 8-K | — | 2021-11-09 | — | |
| 10-Q | — | 2021-11-09 | 2021-09-30 | |
| 8-K | — | 2021-08-16 | — | |
| 10-Q | — | 2021-08-03 | 2021-06-30 | |
| 8-K | — | 2021-07-29 | — | |
| 8-K | — | 2021-07-21 | — | |
| 8-K | — | 2021-07-14 | 2021-07-12 | |
| 8-K | — | 2021-06-07 | 2021-06-04 | |
| DEFA14A | — | 2021-05-18 | — | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| 8-K | — | 2021-05-03 | — | |
| DEF 14A | — | 2021-04-23 | 2021-06-04 | |
| DEFA14A | — | 2021-04-23 | — | |
| 10-K | — | 2021-02-24 | 2020-12-31 | |
| 8-K | — | 2021-02-03 | — | |
| 8-K | — | 2021-01-28 | 2021-01-25 | |
| 8-K | — | 2020-12-21 | 2020-12-18 | |
| 8-K | — | 2020-12-16 | 2020-12-15 | |
| 8-K/A | — | 2020-12-10 | 2020-10-01 | |
| 8-K | — | 2020-12-03 | 2020-12-02 | |
| 8-K | — | 2020-11-23 | — | |
| DEF 14A | — | 2020-11-12 | 2020-12-15 | |
| 10-Q | — | 2020-11-06 | 2020-09-30 | |
| 8-K | — | 2020-10-30 | 2020-10-26 | |
| 8-K | — | 2020-10-30 | — | |
| PRE 14A | — | 2020-10-30 | 2020-12-15 | |
| 8-K | — | 2020-10-20 | — | |
| 8-K | — | 2020-10-13 | 2020-10-11 | |
| 8-K | — | 2020-10-01 | — | |
| SC TO-T/A | — | 2020-09-30 | — | |
| 8-K | — | 2020-09-23 | 2020-09-21 | |
| SC TO-T/A | — | 2020-09-16 | — | |
| SC TO-T/A | — | 2020-09-11 | — | |
| 8-K | — | 2020-09-10 | 2020-09-08 | |
| SC TO-T | — | 2020-08-31 | — | |
| SC TO-C | — | 2020-08-11 | — | |
| SC TO-C | — | 2020-08-11 | — | |
| 8-K | — | 2020-08-11 | 2020-08-10 | |
| 10-Q | — | 2020-08-07 | 2020-06-30 |
Showing 101–150 of 163 filings
Key facts
CIK
886163
CUSIP
53220K504
13F (30d)
134 filings
125 filers
Visit website
Investor relations